Notably, an increasing amount of evidence has indicated that ovarian cancer cells can polarize TAMs toward the M2 phenotype by upregulating the expressions of leukemia inhibitory factor (LIF), IL-6, and colony stimulating factor-1 (CSF-1), in the intraperitoneal tumor microenvironment [89, 93, 94]. This evidence concerns the gene IL6 and ovarian carcinoma.